Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    February 2017
  1. YAMAJI H, Murakami T, Hina K, Higashiya S, et al
    Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2017;69:118-126.
    PubMed     Text format     Abstract available


    December 2016
  2. SILVA AF, Bonatti R, Batatinha J, Nearing BD, et al
    The Selective Late Sodium Current Inhibitor, Eleclazine, Unlike Amiodarone, Does Not Alter Defibrillation Threshold or Dominant Frequency of Ventricular Fibrillation.
    J Cardiovasc Pharmacol. 2016 Dec 28. doi: 10.1097/FJC.0000000000000455.
    PubMed     Text format     Abstract available


    November 2016
  3. YAMAJI H, Murakami T, Hina K, Higashiya S, et al
    Safety and Efficacy of Under-dosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  4. YAMAJI H, Murakami T, Hina K, Higashiya S, et al
    Safety and Efficacy of Under-dosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    J Cardiovasc Pharmacol. 2016 Nov 22. doi: 10.1097/FJC.0000000000000448.
    PubMed     Text format     Abstract available


  5. BEATCH GN, Bhirangi K, Juul-Moller S, Rustige J, et al
    Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation in the Asia-Pacific region: a phase 3 randomized controlled trial.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  6. GARCIA-PEDRAZA JA, Garcia M, Martin ML, Eleno N, et al
    Chronic sarpogrelate treatment reveals 5-HT7 receptor in the serotonergic inhibition of the rat vagal bradycardia.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  7. SAIRAKU A, Nakano Y, Suenari K, Tokuyama T, et al
    Dexmedetomidine depresses sinoatrial and atrioventricular nodal function without any change in atrial fibrillation inducibility.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  8. WEI X, Zhu A, Zhang Y, Yao S, et al
    Pre- and delayed treatments with ranolazine ameliorate ventricular arrhythmias and Nav1.5 downregulation in ischemic/reperfused rat hearts.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  9. AMINO M, Inokuchi S, Yoshioka K, Nakagawa Y, et al
    Does antiarrhythmic drug during cardio-pulmonary resuscitation improve the one-month survival: The SOS-KANTO 2012 study.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  10. ZAMAN JA, Baykaner T, Narayan SM
    New Mechanism-based Approaches to Ablating Persistent AF: Will Drug Therapy Soon Be Obsolete?
    J Cardiovasc Pharmacol. 2016;67:1-8.
    PubMed     Text format     Abstract available


    December 2015
  11. ZHANG L, Gao S
    Systematic Review and Meta-analysis of Atrial Fibrillation Prophylaxis following Lung Surgery.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  12. HOEKER GS, Hanafy MA, Oster RA, Bers DM, et al
    Reduced Arrhythmia Inducibility with Calcium/Calmodulin-Dependent Protein Kinase II Inhibition in Heart Failure Rabbits.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  13. LU Y, Sun J, Zhou X, Zhang L, et al
    The effect of low-level vagus nerve stimulation on cardiac remodeling in a rapid atrial pacing-induced canine model of atrial fibrillation.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  14. NATTEL S, Dobrev D
    Innovative therapeutics for atrial fibrillation: Imminent breakthroughs or much ado about nothing?
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format    


  15. WANG ZQ, Zhang R, Chen MT, Wang QS, et al
    Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
    J Cardiovasc Pharmacol. 2015;66:270-5.
    PubMed     Text format     Abstract available


    August 2015
  16. CHEN M, Zhou X, Liu Q, Sheng X, et al
    Left-sided Noninvasive Vagus Nerve Stimulation Suppresses Atrial Fibrillation by Up-regulating Atrial Gap Junctions in Canines.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  17. DONAHUE JK
    Biological therapies for atrial fibrillation: ready for prime time?
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  18. YU HD, Xia S, Zha CQ, Deng SB, et al
    Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction.
    J Cardiovasc Pharmacol. 2015;65:587-92.
    PubMed     Text format     Abstract available


    May 2015
  19. ZHANG L, Po SS, Wang H, Scherlag BJ, et al
    Autonomic remodeling: How atrial fibrillation begets atrial fibrillation in the first 24 hours.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  20. DARBAR D
    The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics - Is Personalized Therapy in Sight?
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  21. EL-HAOU S, Ford JW, Milnes JT
    Novel K+ channel targets in atrial fibrillation drug development - where are we?
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  22. DINESS JG, Kirchhoff JE, Sheykhzade M, Jespersen T, et al
    Anti-arrhythmic effect of either negative modulation or blockade of small conductance Ca2+ activated K+ channels on ventricular fibrillation in guinea pig Langendorff perfused heart.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    February 2015
  23. HUANG J, Lin YC, Hileman S, Martin KH, et al
    PP2 prevents isoproterenol stimulation of cardiac pacemaker activity.
    J Cardiovasc Pharmacol. 2015;65:193-202.
    PubMed     Text format     Abstract available


    January 2015
  24. GHOLAMZADEH A, Amini S, Mohammadpour AH, Vahabzadeh M, et al
    Erythropoietin reduces post-PCI arrhythmias in patients with ST-elevation myocardial infarction.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    September 2014
  25. OROSZ S, Sarusi A, Csik N, Papp JG, et al
    Assessment of efficacy of proarrhythmia biomarkers in isolated rabbit hearts with attenuated repolarization reserve.
    J Cardiovasc Pharmacol. 2014;64:266-76.
    PubMed     Text format     Abstract available


    June 2014
  26. LIAO K, Yu L, He B, Huang B, et al
    Carotid Baroreceptor Stimulation Prevents Arrhythmias Induced by Acute Myocardial Infarction through Autonomic Modulation.
    J Cardiovasc Pharmacol. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: